XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.350
+0.070 (3.07%)
Nov 25, 2025, 4:00 PM EST - Market closed
XBiotech Market Cap
XBiotech has a market cap or net worth of $71.65 million as of November 26, 2025. Its market cap has decreased by -68.04% in one year.
Market Cap
71.65M
Enterprise Value
-75.72M
1-Year Change
-68.04%
Ranking
Category
Stock Price
$2.35
Market Cap Chart
Since April 15, 2015, XBiotech's market cap has decreased from $737.40M to $71.65M, a decrease of -90.28%. That is a compound annual growth rate of -19.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 69.50M | -42.28% |
| Dec 31, 2024 | 120.40M | -1.07% |
| Dec 29, 2023 | 121.70M | 13.95% |
| Dec 30, 2022 | 106.80M | -68.43% |
| Dec 31, 2021 | 338.30M | -26.12% |
| Dec 31, 2020 | 457.90M | -40.29% |
| Dec 31, 2019 | 766.90M | 321.37% |
| Dec 31, 2018 | 182.00M | 30.37% |
| Dec 29, 2017 | 139.60M | -57.50% |
| Dec 30, 2016 | 328.50M | -6.09% |
| Dec 31, 2015 | 349.80M | -52.56% |
| Apr 15, 2015 | 737.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 958.20B |
| Johnson & Johnson | 496.44B |
| AbbVie | 405.63B |
| UnitedHealth Group | 289.01B |
| AstraZeneca | 283.06B |
| Merck & Co. | 249.20B |
| Novartis AG | 244.50B |
| Abbott Laboratories | 221.17B |